The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Monakhov S.A.

I.M. Sechenov Moscow Medical Academy

Radical therapy of acne

Authors:

Monakhov S.A.

More about the authors

Read: 11904 times


To cite this article:

Monakhov SA. Radical therapy of acne. Russian Journal of Clinical Dermatology and Venereology. 2012;10(1):39‑48. (In Russ.)

Recommended articles:
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Clinical discussion of patients with follicular occlusion syndrome and como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):596-603
Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):651-656

References:

  1. Adaskevich V.P. Akne vul'garnye i rozovye. M: Meditsinskaya kniga, N. Novgorod: Izdatel'stvo NGMA 2003;160.
  2. Guzev K.S., Nozdrin V.I. Novye otechestvennye lekarstvennye sredstva s retinoidami. M: Izd-vo FNPP "Retinoidy" 2003.
  3. Ivanov O.L., Monakhov S.A. B'yuti kontratseptsiya s kosmeticheskim effektom. Novaya apteka 2010; 5: 128-129.
  4. Marri R., Grenner D., Meies P., Roduell V. Biokhimiya cheloveka. M: Mir 1993; 2: 205-220, 228-246.
  5. Monakhov S.A. Retinoidy kak chastichnye agonisty retseptorov RAR i RXR pri akne. Fundamental'nye nauki i progress klinicheskoi meditsiny: Sbornik tezisov. M: Russkii vrach 2004; 340-341.
  6. Samgin M.A., Monakhov S.A. Sovremennyi vzglyad na terapiyu akne retinoidami. Ros zhurn kozhn i ven bol 2003; 5: 59-65.
  7. Samgin M.A., Monakhov S.A. Akne (lektsiya). Ros zhurn kozhn i ven bol 2005; 3: 45-52.
  8. Amichai B., Grunwald M.H. Isotretinoin in dermatology. J Dermatol Treat 2000; 11: 219-240.
  9. Bikers D.R. Is isotretinoin a precursor? New results from experimental studies. Data of symposium "New perspectives in the therapy with oral isotretinoin". Ed. F. Hoffman-La Roche. Paris 2002.
  10. Cunliffe W.J., Holland D.B., Clark S.M., Stables G.L. Comedonogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 6: 1084-1091.
  11. Dates from registration file of the inthenlion. LABORATORIES SMB S.A.
  12. ISOPK.03.04 Version 1.2003.
  13. Kang S., Voorhees J.J. Topical retinoids. In: Dermatology in general medicine. 5th ed. Eds. N.B. Fitzpatrick, A.Z. Eisen, K. Wolf et al. New York: McGraw-Hill 1999; 2726-2732.
  14. Levin A.A., Sturzenbecker L.J., Kazmer S. et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR-α. Nature 1992; 355: 359-361.
  15. Fitzpatrick T.B., Eisen A.Z., Wolf K. et al. (eds.). Regulation of epidermal proliferation and differentiation. In: Dermatology in general medicine. 5th ed. New York: McGraw-Hill 1999; 80-82.
  16. Saurat J.-H. Are isotretinoin metabolism and receptor binding important for acne therapy. Data of symposium "New perspectives in the therapy with oral isotretinoin". Eds. F. Hoffman-La Roche. Paris 2002.
  17. SMB-ISO-SD011, Bel'giya. Odnokratnaya doza, 2 skhemy terapii, perekrestnoe randominizirovannoe issledovanie, pri uslovii priema preparata s pishchei.
  18. Zouboulis C.C., Xia L., Akamatsu H. et al. The human sebocyte culture model provides new insights into development and management of seborrhea and acne. Dermatol Venereol 1998; 196: 1: 21-31.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.